FMP
Nanobiotix S.A.
NBTX
NASDAQ
Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. Nanobiotix S.A. has a partnership with LianBio to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. The company was incorporated in 2003 and is headquartered in Paris, France.
3.19 USD
0 (0%)
About
ceo
Mr. Laurent Levy Ph.D.
sector
Healthcare
industry
Biotechnology
website
https://www.nanobiotix.comexchange
NASDAQ
Description
Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. Nanobiotix S.A. has a partnership with LianBio to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. The company was incorporated in 2003 and is headquartered in Paris, France.
CIK
0001760854
ISIN
US63009J1079
CUSIP
63009J107
Address
60 rue de Wattignies
Phone
33 1 40 26 04 70
Country
FR
Employee
108
IPO Date
Dec 11, 2020
Key Executives
Name
Title
Pay
Year Born
Mr. Craig West CFA
Senior Vice President of Investor Relati...
0
N/A
Mr. Brandon Owens
Vice President of Strategic Marketing & ...
0
N/A
Mr. Bart Van Rhijn
Chief Financial & Business Officer and M...
680.8k
1974
Mr. Earl J. Bergey Ph.d.
Co-Founder
0
1955
Mr. Laurent Levy Ph.D.
Co-Founder, President of the Executive B...
857.84k
1973
Ms. Anne-Juliette Hermant M.A.
Chief People Officer & Member of Executi...
427.61k
1974
Dr. Louis Kayitalire M.D.
Chief Medical Officer & Member of Execut...
682.52k
1959
Ms. Margaret Galluzzi
Vice President & Global Head of Clinical...
0
N/A
Dr. Leonard A. Farber M.D.
Chief Clinical and Medical Affairs Offic...
0
N/A
As of December 31, 2024, the total employee count stands at 108, with compensation values reflecting the last fiscal year ending on that date. Pay encompasses salary, bonuses, etc., All figures are in USD.
